334 related articles for article (PubMed ID: 18668539)
21. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
[TBL] [Abstract][Full Text] [Related]
22. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice.
Pinto LG; Cunha TM; Vieira SM; Lemos HP; Verri WA; Cunha FQ; Ferreira SH
Pain; 2010 Feb; 148(2):247-256. PubMed ID: 19969421
[TBL] [Abstract][Full Text] [Related]
23. Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors.
Wieser V; Adolph TE; Enrich B; Kuliopulos A; Kaser A; Tilg H; Kaneider NC
Gut; 2017 May; 66(5):930-938. PubMed ID: 26858343
[TBL] [Abstract][Full Text] [Related]
24. CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo.
Zhang XW; Liu Q; Wang Y; Thorlacius H
Br J Pharmacol; 2001 Jun; 133(3):413-21. PubMed ID: 11375258
[TBL] [Abstract][Full Text] [Related]
25. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat.
Garau A; Bertini R; Mosca M; Bizzarri C; Anacardio R; Triulzi S; Allegretti M; Ghezzi P; Villa P
Eur Cytokine Netw; 2006 Mar; 17(1):35-41. PubMed ID: 16613761
[TBL] [Abstract][Full Text] [Related]
26. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2.
Moriconi A; Cesta MC; Cervellera MN; Aramini A; Coniglio S; Colagioia S; Beccari AR; Bizzarri C; Cavicchia MR; Locati M; Galliera E; Di Benedetto P; Vigilante P; Bertini R; Allegretti M
J Med Chem; 2007 Aug; 50(17):3984-4002. PubMed ID: 17665889
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis.
Min SH; Wang Y; Gonsiorek W; Anilkumar G; Kozlowski J; Lundell D; Fine JS; Grant EP
Biochem Biophys Res Commun; 2010 Jan; 391(1):1080-6. PubMed ID: 20004647
[TBL] [Abstract][Full Text] [Related]
28. CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation.
Wu F; Zhao Y; Jiao T; Shi D; Zhu X; Zhang M; Shi M; Zhou H
J Neuroinflammation; 2015 May; 12():98. PubMed ID: 25990934
[TBL] [Abstract][Full Text] [Related]
29. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation.
Zhou H; Andonegui G; Wong CH; Kubes P
J Immunol; 2009 Oct; 183(8):5244-50. PubMed ID: 19786543
[TBL] [Abstract][Full Text] [Related]
30. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2.
Brown CR; Blaho VA; Loiacono CM
J Immunol; 2003 Jul; 171(2):893-901. PubMed ID: 12847259
[TBL] [Abstract][Full Text] [Related]
32. TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expression.
Inoue A; Matsumoto I; Tanaka Y; Umeda N; Takai C; Kawaguchi H; Ebe H; Yoshida H; Matsumoto Y; Segawa S; Takahashi S; Sumida T
Sci Rep; 2016 Dec; 6():38684. PubMed ID: 27995997
[TBL] [Abstract][Full Text] [Related]
33. Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1β production.
Pinto LG; Talbot J; Peres RS; Franca RF; Ferreira SH; Ryffel B; Aves-Filho JC; Figueiredo F; Cunha TM; Cunha FQ
Arthritis Res Ther; 2015 Sep; 17(1):235. PubMed ID: 26330334
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
[TBL] [Abstract][Full Text] [Related]
35. Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1.
Conte Fde P; Barja-Fidalgo C; Verri WA; Cunha FQ; Rae GA; Penido C; Henriques Md
J Leukoc Biol; 2008 Sep; 84(3):652-60. PubMed ID: 18515326
[TBL] [Abstract][Full Text] [Related]
36. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation.
Citro A; Cantarelli E; Maffi P; Nano R; Melzi R; Mercalli A; Dugnani E; Sordi V; Magistretti P; Daffonchio L; Ruffini PA; Allegretti M; Secchi A; Bonifacio E; Piemonti L
J Clin Invest; 2012 Oct; 122(10):3647-51. PubMed ID: 22996693
[TBL] [Abstract][Full Text] [Related]
37. Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice.
Godaly G; Hang L; Frendéus B; Svanborg C
J Immunol; 2000 Nov; 165(9):5287-94. PubMed ID: 11046063
[TBL] [Abstract][Full Text] [Related]
38. DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain.
Lopes AH; Brandolini L; Aramini A; Bianchini G; Silva RL; Zaperlon AC; Verri WA; Alves-Filho JC; Cunha FQ; Teixeira MM; Allegretti M; Cunha TM
Pharmacol Res; 2016 Jan; 103():69-79. PubMed ID: 26592483
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2.
Casilli F; Bianchini A; Gloaguen I; Biordi L; Alesse E; Festuccia C; Cavalieri B; Strippoli R; Cervellera MN; Di Bitondo R; Ferretti E; Mainiero F; Bizzarri C; Colotta F; Bertini R
Biochem Pharmacol; 2005 Feb; 69(3):385-94. PubMed ID: 15652230
[TBL] [Abstract][Full Text] [Related]
40. KLF2 regulates neutrophil migration by modulating CXCR1 and CXCR2 in asthma.
Zhu LM; Zeng D; Lei XC; Huang J; Deng YF; Ji YB; Liu J; Dai FF; Li YZ; Shi DD; Zhu YQ; Dai AG; Wang Z
Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165920. PubMed ID: 32800946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
